Clinical trial
The Effects of Procrit (Epoetin Alfa) on Hemoglobin Symptom Distress and Quality of Life During Chemotherapy in Lymphoma Patients With Mild to Moderate Anemia A Multicenter Trial
NCT00003341 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of Procrit (Epoetin Alfa) on Hemoglobin Symptom Distress and Quality of Life During Chemotherapy in Lymphoma Patients With Mild to Moderate Anemia A Multicenter Trial
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 31, 1997
- Completion date
- September 30, 2003
- Enrollment
- 275 (estimated)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.